Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

AIMS: To investigate changes in glycated hemoglobin (HbA1c), body weight (BW), and systolic blood pressure (SBP) in type 2 diabetes (T2D) primary care patients initiating dapagliflozin treatment. METHODS: T2D patients who started dapagliflozin in 985 general and 32 diabetologist practices (Disease A...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheerer, Markus F, Rist, Roland, Proske, Orm, Meng, Annika, Kostev, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096728/
https://www.ncbi.nlm.nih.gov/pubmed/27822077
http://dx.doi.org/10.2147/DMSO.S116243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096728/
https://www.ncbi.nlm.nih.gov/pubmed/27822077
http://dx.doi.org/10.2147/DMSO.S116243

Ejemplares similares